p53 and cancer therapy: a double-edged sword.

The Journal of clinical investigation ·Vol. 104 ·No. 3 ·1999-08-00 ·Pages 223-5

McGill G, Fisher DE

Abstract

暂无摘要

MeSH Terms

Animals Colorectal Neoplasms/drug therapy,pathology Drug Resistance, Neoplasm Humans Tumor Suppressor Protein p53/physiology

Chemicals

Tumor Suppressor Protein p53

Authors & Affiliations

2 authors, click to expand affiliations / ORCID

McGill G

Division of Pediatric Hematology/Oncology, Graduate Program in Biological and Biomedical Sciences, Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115, USA.

Fisher D E

References (20)

20 references, click to expand

A genetic model for colorectal tumorigenesis.
Cell. 1990 Jun 1;61(5):759-67 PMID: 2188735
Disruption of p53 in human cancer cells alters the responses to therapeutic agents.
J Clin Invest. 1999 Aug;104(3):263-9 PMID: 10430607
Induction of apoptosis in fibroblasts by c-myc protein.
Cell. 1992 Apr 3;69(1):119-28 PMID: 1555236
Cancer. p53, guardian of the genome.
Nature. 1992 Jul 2;358(6381):15-6 PMID: 1614522
p53-dependent apoptosis modulates the cytotoxicity of anticancer agents.
Cell. 1993 Sep 24;74(6):957-67 PMID: 8402885
p53-dependent apoptosis in the absence of transcriptional activation of p53-target genes.
Nature. 1994 Jul 21;370(6486):220-3 PMID: 8028670
Apoptosis in cancer therapy: crossing the threshold.
Cell. 1994 Aug 26;78(4):539-42 PMID: 8069905
p53 status and the efficacy of cancer therapy in vivo.
Science. 1994 Nov 4;266(5186):807-10 PMID: 7973635
Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21waf1/cip1.
Genes Dev. 1994 Dec 1;8(23):2817-30 PMID: 7995520
Tumor suppressor p53 is a direct transcriptional activator of the human bax gene.
Cell. 1995 Jan 27;80(2):293-9 PMID: 7834749
The human papilloma virus 16E6 gene sensitizes human mammary epithelial cells to apoptosis induced by DNA damage.
Proc Natl Acad Sci U S A. 1995 Aug 15;92(17):7829-33 PMID: 7644500
Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours.
Nature. 1996 Jan 4;379(6560):88-91 PMID: 8538748
Inactivation of p53 enhances sensitivity to multiple chemotherapeutic agents.
Cancer Res. 1996 Feb 15;56(4):892-8 PMID: 8631030
p53 mutations as a possible predictor of response to chemotherapy in metastatic colorectal carcinomas.
Int J Cancer. 1996 Jun 21;69(3):190-2 PMID: 8682586
Loss of matrix adhesion triggers rapid transformation-selective apoptosis in fibroblasts.
J Cell Biol. 1997 Aug 25;138(4):901-11 PMID: 9265655
A model for p53-induced apoptosis.
Nature. 1997 Sep 18;389(6648):300-5 PMID: 9305847
Ki-ras mutation and p53 overexpression predict the clinical behavior of colorectal cancer: a Southwest Oncology Group study.
Cancer Res. 1998 Mar 15;58(6):1149-58 PMID: 9515799
Regulation of proliferation-survival decisions during tumor cell hypoxia.
Mol Cell Biol. 1998 May;18(5):2845-54 PMID: 9566903
Oncogene-dependent regulation of caspase activation by p53 protein in a cell-free system.
J Biol Chem. 1998 Oct 23;273(43):28378-83 PMID: 9774464
Apoptosis, p53, and tumor cell sensitivity to anticancer agents.
Cancer Res. 1999 Apr 1;59(7):1391-9 PMID: 10197600

Article Info

Journal

The Journal of clinical investigation

Abbr.

J Clin Invest

ISSN

0021-9738

DOI

10.1172/JCI7861

Published

1999-08-00

Pages

223-5

Language

English

Region

United States

NLM ID

7802877

PMCID

PMC408427

Subset

Corrections

CommentOn

PMID: 10430607

External Links

PubMed source DOI: 10.1172/JCI7861 PMC Full Text View journal details

Analysis Services

p53 and cancer therapy: a double-edged sword.

Contact

WeChat Official Account